NEW DELHI India is likely to allow a smaller gap between AstraZeneca COVID-19 vaccine doses for inoculations being carried out privately, in line with a court order, two sources told Reuters.
NEW DELHI India's government will not buy COVID-19 shots from Pfizer/BioNTech and Moderna, three government sources told Reuters, mainly because domestic output of more affordable and easier-to-store vaccines has jumped https://www.reuters.com/world/india/how-india-flipped-its-vaccine-fortunes-2021-09-21.
NEW DELHI Only months ago, India ran so short of COVID-19 vaccines that computer experts wrote software code https://www.reuters.com/world/india/high-tech-hunt-scarce-covid-19-vaccines-india-raises-fear-fairness-2021-05-05 to help people snag scarce immunisation slots and the then health minister had to constantly battle opposition criticism on social media.
NEW DELHI (Reuters) -India will resume exports of COVID-19 vaccines in the October quarter, prioritising the global vaccine-sharing platform COVAX and neighbouring countries first as supplies rise, the health minister said on Monday.
NEW DELHI India gave a record 22.6 million vaccinations on Friday, three times the average daily total during the past month, as some states organised special inoculation drives on Prime Minister Narendra Modi's birthday.
NEW DELHI India is considering resuming exports of COVID-19 vaccines soon, mainly to Africa, as it has partly immunised a majority of its adults and supplies have surged, a source with knowledge of the matter told Reuters.
BHUBANESWAR, India A study https://www.researchsquare.com/article/rs-888762/v1 of 614 fully vaccinated health workers in India found a "significant" drop in their COVID-fighting antibodies within four months of the first shot.